Imugene doses first patient in “groundbreaking” Phase 1 OASIS clinical trial
Imugene doses first patient in “groundbreaking” Phase 1 OASIS …
Oct 26, 2023
proactiveinvestors.com.au
Groundbreaking cancer trial: Imugene’s CF33 advances in clinical success
Groundbreaking cancer trial: Imugene’s CF33 advances in clini…
Nov 13, 2024
proactiveinvestors.com.au
Imugene with Proactive at ASX Small and Mid Cap Conference
Imugene with Proactive at ASX Small and Mid Cap Conference
Mar 26, 2024
proactiveinvestors.com.au
Imugene has cancer vaccine trial data published in prestigious medical journal
Imugene has cancer vaccine trial data published in prestigious med…
4 months ago
proactiveinvestors.com.au
Imugene reveals new clinical data for HER-Vaxx vaccine showing cancer-fighting response
Imugene reveals new clinical data for HER-Vaxx vaccine showing ca…
Jul 8, 2019
proactiveinvestors.com.au
Groundbreaking cancer trial: Imugene’s CF33 advances in clinical success
16:02
Groundbreaking cancer trial: Imugene’s CF33 advances in clini…
1.8K viewsNov 14, 2024
YouTubeImugene Limited
Imugene’s Phase 1 onCARlytics clinical trial doses first patient in intravenous monotherapy arm
Imugene’s Phase 1 onCARlytics clinical trial doses first patient in i…
Feb 14, 2024
proactiveinvestors.com.au
Imugene advances Phase 1 MAST trial for cancer-killing VAXINIA virus
Nov 2, 2023
proactiveinvestors.com
Imugene secures FDA approval for two clinical trials of promising onc…
Dec 13, 2021
proactiveinvestors.com
Imugene prepares pivotal azer-cel trial with FDA - ICYMI
4 months ago
proactiveinvestors.com
Imugene hits 82% response rate in blood cancer trial - ICYMI
3 months ago
proactiveinvestors.com.au
Imugene doses first patient for VAXINIA bile tract cancer trial in M…
Jul 9, 2024
proactiveinvestors.com
Imugene reports progress across clinical pipeline and bolsters capit…
7 months ago
proactiveinvestors.com
Imugene doses first patient in intravenous monotherapy arm of …
Feb 14, 2024
proactiveinvestors.com
Imugene advances to cohort three of VAXINIA monotherapy dose esc…
Apr 4, 2023
proactiveinvestors.com.au
Imugene Phase 1 onCARlytics trial doses first patient in intratumoura…
Nov 11, 2024
proactiveinvestors.com.au
Imugene welcomes new dose escalation in CHECKvacc clinical t…
Jul 7, 2023
proactiveinvestors.co.uk
Imugene progresses VAXINIA MAST trial; appoints new chief medical o…
Sep 4, 2023
proactiveinvestors.co.uk
Imugene gets development roadmap for cancer vaccine from FDA meet…
Mar 20, 2019
proactiveinvestors.com.au
Imugene and City of Hope dose first patient in cohort 3 of phase 1 trial …
Aug 9, 2022
proactiveinvestors.com
Imugene VAXINIA achieves complete response in patient two …
Nov 4, 2024
proactiveinvestors.com.au
Imugene to open new PD1-Vaxx Phase 2 bowel cancer clinical trial …
Dec 5, 2023
proactiveinvestors.com.au
Imugene doses first patient in IV arm of Phase 1 onCARlytics trial t…
Jun 23, 2024
proactiveinvestors.com.au
Imugene sees positive early signs in VAXINIA trial; “may be potent anti …
Nov 6, 2023
proactiveinvestors.com.au
Imugene wins US FDA approval to begin onCARlytics first-in-class cl…
May 19, 2023
proactiveinvestors.com.au
18:36
Biotech Unlocked - IMUGENE ASX:IMU
663 viewsNov 18, 2021
YouTubeASX
Imugene opens higher as novel cancer-killing virus VAXINIA is gra…
Nov 27, 2023
proactiveinvestors.com.au
Imugene and City of Hope dose first patient in phase 1 trial to test canc…
May 18, 2022
proactiveinvestors.com.au
FDA backs Imugene’s azer-cel treatment plan - ICYMI
2 months ago
proactiveinvestors.com
See more videos
Static thumbnail place holder